In our study, while MyD88 knockdown yields reduced cardiac hypertrophy after MI and TAC [24,25], TRIF apparently has little influence on the development of afterload-induced cardiomyocyte hypertrophy. Here, MYD88 is linked to cardiac hypertrophy.